The United States recorded its highest annual total of confirmed measles infections in 35 years during 2026, with 2,318 cases reported across the country. Data indicates that 69 percent of these cases occurred in individuals aged 19 or younger, and one-fifth involved children under five. A significant majority, 93 percent, of those infected were unvaccinated.
This rise in cases comes as kindergarten vaccination coverage for measles, mumps, and rubella (MMR) was reported at 92.5 percent nationally. This figure remains below the 95 percent threshold generally considered necessary to achieve effective herd immunity, a level that helps protect vulnerable populations who cannot be vaccinated.
Internationally, the Democratic Republic of the Congo recently reported nearly 3,000 confirmed Ebola cases following a comprehensive data review. This outbreak has resulted in more than 1,269 deaths, underscoring ongoing global health challenges.
Federal health agencies have also been actively investigating foodborne illness outbreaks. The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) expanded an investigation into a cyclospora outbreak. This outbreak, linked to shredded iceberg lettuce imported from central Mexico, has affected nine states, reporting 1,947 cases and 98 hospitalizations. No deaths have been attributed to this outbreak, and the implicated lettuce was recalled, leading to the temporary closure of the processing facility involved.
In a separate food safety development, Midwest Poultry Services initiated a recall of nearly 1.6 million dozen eggs due to a potential Salmonella risk. Such recalls highlight the continuous vigilance required within the food supply chain to prevent widespread illness.
On the corporate and regulatory front, a federal judge dismissed a shareholder lawsuit against Abbott Laboratories. The suit concerned the company’s 2022 powdered infant-formula recall from its Sturgis, Michigan, plant. Judge Steven Seeger ruled that the shareholders had not provided sufficient evidence to demonstrate that the company intended to deceive them, a key legal standard in such cases.
Pharmaceutical policy and access have also seen recent shifts. Merck signed agreements covering an experimental HIV pill in 129 countries, aiming to broaden access to new treatments. Concurrently, the FDA made several regulatory decisions, including the exclusion of the peptide emideltide from pharmacy-compounding lists and recommending Semax for inclusion. A Virginia federal judge also issued an order requiring the FDA to reassess special licensing requirements for prescribing mifepristone, a medication used for medical abortion.
Why it matters in Greenwood
The confluence of national health trends, from rising measles cases to food safety alerts and pharmaceutical policy shifts, directly impacts the well-being of residents in Greenwood. The decline in national MMR vaccination rates, for instance, poses a tangible concern for institutions like Greenwood County School Districts 50, 51, and 52, where maintaining high immunization levels is critical for student health and preventing localized outbreaks. Similarly, food recalls and drug policy changes have direct implications for Self Regional Healthcare, the region’s primary healthcare provider, which must navigate evolving public health guidelines and ensure access to safe food and effective medications for its patients. These broader developments underscore the interconnectedness of national health policy and local community health in Greenwood.
